Literature DB >> 2988595

Salmon and human calcitonin like material in lung cancer.

C Gropp, W Luster, K Havemann.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 2988595      PMCID： PMC1977084          DOI： 10.1038/bjc.1985.136

Source DB:  PubMed          Journal:  Br J Cancer        ISSN： 0007-0920            Impact factor:   7.640


× No keyword cloud information.
  24 in total

1.  Ectopic secretion of calcitonin by oat-cell carcinoma.

Authors:  O L Silva; K L Becker; A Primack; J Doppman; R H Snider
Journal:  N Engl J Med       Date:  1974-05-16       Impact factor: 91.245

2.  Carcinoembryonic antigen in patients with carcinoma of the lung.

Authors:  R G Vincent; T M Chu
Journal:  J Thorac Cardiovasc Surg       Date:  1973-08       Impact factor: 5.209

3.  The carcinoembryonic antigen assay in bronchogenic carcinoma.

Authors:  J P Concannon; M H Dalbow; G A Liebler; K E Blake; C S Weil; J W Cooper
Journal:  Cancer       Date:  1974-07       Impact factor: 6.860

4.  Plasma immunoreactive calcitonin in lung cancer.

Authors:  B A Roos; A W Lindall; S B Baylin; J A O'Neil; A L Frelinger; R S Birnbaum; P W Lambert
Journal:  J Clin Endocrinol Metab       Date:  1980-04       Impact factor: 5.958

5.  Carcinoembryonic antigen and ferritin in patients with lung cancer before and during therapy.

Authors:  C Gropp; K Havemann; F G Lehmann
Journal:  Cancer       Date:  1978-12       Impact factor: 6.860

6.  Characterization of the immunochemical forms of calcitonin released by a medullary thyroid carcinoma in tissue culture.

Authors:  D Goltzman; A S Tischler
Journal:  J Clin Invest       Date:  1978-02       Impact factor: 14.808

7.  Salmon and human calcitonin-like peptides coexist in the human thyroid and brain.

Authors:  J A Fischer; P H Tobler; H Henke; F A Tschopp
Journal:  J Clin Endocrinol Metab       Date:  1983-12       Impact factor: 5.958

8.  Calcitonin as a tumor marker. Use of the radioimmunoassay for calcitonin in the postoperative evaluation of patients with medullary thyroid carcinoma.

Authors:  D Goltzman; J T Potts; R C Ridgway; F Maloof
Journal:  N Engl J Med       Date:  1974-05-09       Impact factor: 91.245

9.  Immunochemical heterogeneity of calcitonin in plasma of patients with medullary thryoid carcinoma.

Authors:  G W Sizemore; H Hpeath; J M Larson
Journal:  J Clin Invest       Date:  1975-05       Impact factor: 14.808

10.  Immunoreactive calcitonin production by human lung carcinoma cells in culture.

Authors:  M Ellison; D Woodhouse; C Hillyard; M Dowsett; R C Coombes; E D Gilby; P B Greenberg; A M Neville
Journal:  Br J Cancer       Date:  1975-09       Impact factor: 7.640
View more
  5 in total

1.  Calcitonin inhibits prolactin promoter activity in rat pituitary GGH3 cells: evidence for involvement of p42/44 mitogen-activated protein kinase in calcitonin action.

Authors:  Yuan Ren; Ya-Ping Sun; Girish V Shah
Journal:  Endocrine       Date:  2003 Feb-Mar       Impact factor: 3.633

2.  Calcitonin inhibits prolactin gene transcription in rat pituitary cells.

Authors:  Q Xue-Zhang; S M Stanley; G V Shah
Journal:  Endocrine       Date:  1995-06       Impact factor: 3.633

3.  Serum procalcitonin as a predictor of infectious complications after pancreaticoduodenectomy: review of the literature and our experience.

Authors:  Hiroya Iida; Hiromitsu Maehira; Haruki Mori; Masaji Tani
Journal:  Surg Today       Date:  2019-04-16       Impact factor: 2.549

4.  A synthetic peptide derived from mouse pituitary calcitonin cDNA sequence exhibits potent inhibition of prolactin secretion and prolactin mRNA abundance in primary mouse pituitary cells.

Authors:  Trupti Kulkarni-Paranjape; Girish V Shah
Journal:  Endocrine       Date:  2007-06       Impact factor: 3.633

5.  Bluephage, a method for efficient detection of somatic coliphages in one hundred milliliter water samples.

Authors:  Javier Méndez; Daniel Toribio-Avedillo; Raquel Mangas-Casas; Judit Martínez-González
Journal:  Sci Rep       Date:  2020-02-19       Impact factor: 4.379
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.